Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chinese Academy of Medical Sciences and Peking Union Medical College XO compound XO-33
- Development stage
- Unknown
- Lead developer
- Chinese Academy of Medical Sciences and Peking Union Medical College
01
Overview
Chinese Academy of Medical Sciences and Peking Union Medical College XO compound XO-33: sourced facts only. name: "After two rounds of screening, six compounds with significant inhibition against XO were identified and the most active one XO-33 showed an IC50 of 23.3 nM." [PMID:35063733]; target: "After two rounds of screening, six compounds with significant inhibition against XO were identified and the most active one XO-33 showed an IC50 of 23.3 nM." [PMID:35063733]; developer: "Beijing Key Laboratory of Active Substance Discovery and Druggability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China." [PMID:35063733]
Beyond the preview
Go deeper on Chinese Academy of Medical Sciences and Peking Union Medical College XO compound XO-33.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Chinese Academy of Medical Sciences and Peking Union Medical College XO compound XO-33.